title: Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?
authors.forename: Didem S
authors.initials: DS
authors.lastname: Dede
authors.forename: Ebru
authors.initials: E
authors.lastname: Sari
authors.forename: Nilufer
authors.initials: N
authors.lastname: Bulut
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000208:ethnology / Q000235:genetics*; D064447:Checkpoint Kinase 2; D017353:Gene Deletion; D020022:Genetic Predisposition to Disease; D006579:Heterozygote; D006801:Humans; D009154:Mutation; D010641:Phenotype; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D012426:Russia
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases